TradeBriefs Editorial

From the Editor's Desk

How Moderna, Home Depot, and others are succeeding with AI

When pharmaceutical company Moderna announced the first clinical trial of a COVID-19 vaccine, it was a proud moment but not a surprising one for Dave Johnson, the company's chief data and artificial intelligence officer.

When Johnson joined the company in 2014, he helped put in place automated processes and AI algorithms to increase the number of small-scale messenger RNA (mRNA) needed to run clinical experiments. This groundwork contributed to Moderna releasing one of the first COVID-19 vaccines (using mRNA) even as the world had only started to understand the virus' threat.

"The whole COVID vaccine development, we're immensely proud of the work that we've done there, and we're immensely proud of the superhuman effort that our people went through to bring it to market so quickly," Johnson said during a bonus episode of the MIT Sloan Management Review podcast "Me, Myself, and AI."

Continued here

TradeBriefs: Newsletters for Decision-Makers!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Want the newsletters, without the promotional mailers?
Get an (ad-free) subscription to TradeBriefs Premium for just $2 per month.

You are here: Home Opinion How Moderna, Home Depot, and others are succeeding with AI.